Green light for Apo-rot as Zur Rose plans buys
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Germany’s Federal Cartel Office has approved DocMorris’ acquisition of mail-order competitor Apo-Rot, paving the way for the deal’s completion. At the same time, DocMorris’ parent company Zur Rose has raised CHF115 million (€99.3 million) for further acquisitions.